# Leukocyte telomere length and circulating MiRNAs in relation to cardiovascular outcomes in older adults

**Authors:** Rossella La Grotta, Paolina Crocco, Aleksandra Leonova, Salvatore Claudio Cosimo, Francesco Morelli, Serena Dato, Giuseppe Passarino, Giuseppina Rose

PMC · DOI: 10.1186/s12877-026-07042-4 · BMC Geriatrics · 2026-02-02

## TL;DR

This study explores how telomere length and specific microRNAs relate to cardiovascular risks in older adults, finding that they independently affect different heart conditions.

## Contribution

The study reveals independent associations between telomere length and miRNAs with specific cardiovascular outcomes in older adults.

## Key findings

- Shorter telomeres were linked to higher atrial fibrillation risk, but not other cardiovascular diseases.
- miR-23a-3p and miR-92a-3p showed opposing associations with atrial fibrillation risk.
- Lower miR-92a-3p levels were associated with increased stroke risk.

## Abstract

Telomere shortening and circulating microRNAs (miRNAs) are recognized molecular hallmarks of biological aging. Both have been implicated in cardiovascular disease (CVD), yet their potential interplay and combined contribution to cardiovascular vulnerability, and potential clinical relevance in older adults remain unclear.

We investigated the associations of leukocyte telomere length (LTL) and five circulating miRNAs (miR-21-5p, miR-23a-3p, miR-34a-5p, miR-92a-3p, and miR-486-5p), previously linked to telomere maintenance and cardiovascular pathology, with CVD outcomes in a cohort of 624 elderly individuals (aged 60–98 years). LTL was measured in all participants, while miRNAs were quantified in a subset of 210 individuals. Logistic regression analyses adjusted for demographic and clinical covariates were applied to assess associations of LTL and miRNAs with overall CVD and specific conditions, including atrial fibrillation (AF), heart failure (HF), ischemic cardiomyopathy (ICM), and stroke.

Shorter LTL was independently associated with higher AF risk (OR = 0.25, 95% CI 0.11–0.65, p = 0.004) but not with other CVD outcomes. In AF, miR-23a-3p and miR-92a-3p were not individually associated with risk but showed opposite directions of association when included together in fully adjusted models (miR-23a-3p protective; miR-92a-3p risk-enhancing), independently of LTL. Lower miR-92a-3p levels were also associated with stroke risk, whereas associations of miR-34a-5p with HF and miR-486-5p with ICM were attenuated after adjustment. No significant correlations were found between LTL and circulating miRNAs.

Shorter telomeres and distinct expression patterns of the analysed miRNAs were independently associated with specific cardiovascular outcomes in older adults, suggesting that these biomarkers reflect complementary molecular aspects of cardiovascular vulnerability in aging. While their addition to conventional risk factors did not significantly improve risk discrimination, they may provide mechanistic insights into biological processes underlying cardiovascular risk in aging populations.

The online version contains supplementary material available at 10.1186/s12877-026-07042-4.

## Linked entities

- **Diseases:** cardiovascular disease (MONDO:0004995), atrial fibrillation (MONDO:0004981), heart failure (MONDO:0005252), stroke (MONDO:0005098)

## Full-text entities

- **Genes:** MIR484 (microRNA 484) [NCBI Gene 619553] {aka MIRN484, hsa-mir-484, mir-484}, MIR486-1 (microRNA 486-1) [NCBI Gene 619554] {aka MIR486, MIRN486, hsa-mir-486, hsa-mir-486-1, mir-486-1}, MLXIP (MLX interacting protein) [NCBI Gene 22877] {aka MIR, MONDOA, bHLHe36}, ALB (albumin) [NCBI Gene 213] {aka FDAHT, HSA, PRO0883, PRO0903, PRO1341}, MIR34A (microRNA 34a) [NCBI Gene 407040] {aka MIRN34A, miRNA34A, mir-34, mir-34a}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, TERT (telomerase reverse transcriptase) [NCBI Gene 7015] {aka CMM9, DKCA2, DKCB4, EST2, PFBMFT1, TCS1}, MIR17HG (miR-17-92a-1 cluster host gene) [NCBI Gene 407975] {aka C13orf25, LINC00048, MIHG1, MIRH1, MIRHG1, NCRNA00048}, TERF2 (telomeric repeat binding factor 2) [NCBI Gene 7014] {aka TRBF2, TRF2}, MIR21 (microRNA 21) [NCBI Gene 406991] {aka MIRN21, hsa-mir-21, miR-21, miRNA21}, MIR215 (microRNA 215) [NCBI Gene 406997] {aka MIRN215, miRNA215, mir-215}
- **Diseases:** ischemic (MESH:D002545), endothelial dysfunction (MESH:D014652), diabetes (MESH:D003920), Alzheimer's (MESH:D000544), chronic kidney disease (MESH:D051436), neuroinflammation (MESH:D000090862), LTL (MESH:D007960), cardiac fibrosis (MESH:D005355), Inflammation (MESH:D007249), arrhythmic (OMIM:212500), hemolysis (MESH:D006461), frailty (MESH:D000073496), obesity (MESH:D009765), Stroke (MESH:D020521), ICM (MESH:D009202), azotaemia (MESH:D053099), AF (MESH:D001281), ischemic injury (MESH:D017202), ischemic stroke (MESH:D002544), CVDs (MESH:D002318), atherosclerotic (MESH:D050197), hypertension (MESH:D006973), chronic (MESH:D002908), HF (MESH:D006333), coronary artery disease (MESH:D003324), telomere dysfunction (MESH:C536801), arrhythmogenic remodelling (MESH:D020257)
- **Chemicals:** uric acid (MESH:D014527), triglycerides (MESH:D014280), Diastolic Blood Pressure (MESH:D004145), ethanol (MESH:D000431), -cholesterol (MESH:D002784), water (MESH:D014867), Ca2 + (-), calcium (MESH:D002118), creatinine (MESH:D003404), chloroform (MESH:D002725), lipid (MESH:D008055)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12955057/full.md

## Figures

4 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12955057/full.md

## References

2 references — full list in the complete paper: https://tomesphere.com/paper/PMC12955057/full.md

---
Source: https://tomesphere.com/paper/PMC12955057